Crownlands Observing Progression With Neurons Study (NCT07611396)
Crownlands Observing Progression With Neurons I (CROWN-I)
🩺 Plain-English Summary (8th-Grade Level)
The CROWN-I Study is an observational study to learn about molecular features of Alzheimer's disease (AD) and mild cognitive impairment (MCI). The primary objective is to identify the molecular and genetic modules that differentiate patient subtypes and predict progression of AD. Participants will visit clinical sites to donate samples multiple times and perform virtual and in-person clinical assessments.
Who can join: Review the eligibility criteria below.
Location: Capital Neurology — Germantown, Maryland
Age range: 55 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Capital Neurology — Germantown, Maryland
📞 Contact the Study Coordinator
Phone: (415) 623-8635
Email: m.sanfilippo@crownlands.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Alzheimer s Disease
- Ultrasonic Debris Clearance to Promote Brain Resilience — Stanford, California
- Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia — Toronto, Ontario
- PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) — Bethesda, Maryland
- Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition — Baton Rouge, Louisiana
- Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device — Chicago, Illinois
Explore by condition: All Alzheimer s Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.